AFTDP | Inherited Frontotemporal Dementia and Amyotrophic Lateral Sclerosis Gene Panel, Varies

This test is intended for establishing a molecular diagnosis for patients with frontotemporal dementia and/or amyotrophic lateral sclerosis (ALS).

ARVGG | Arrhythmogenic Cardiomyopathy Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of a hereditary form of arrhythmogenic cardiomyopathy.

ATAXP | Inherited Ataxia Gene Panel, Varies

This test is intended establishing a molecular diagnosis for patients with ataxia.

BABPB | Babesia species, Molecular Detection, PCR, Blood

This test is intended for initial screening or confirmatory testing for suspected babesiosis during the acute febrile stage of infection in patients from endemic areas, especially when Giemsa-stained peripheral blood smears do not reveal any organisms, or the organism morphology is inconclusive.

BMIPB | Borrelia miyamotoi Detection, PCR, Blood

This test is intended for aiding in the diagnosis of Borrelia miyamotoi infection in conjunction with clinical findings.

BPRPV | Bordetella pertussis and Bordetella parapertussis, Molecular Detection, PCR, Varies

This test is intended as the preferred diagnostic test for the detection of Bordetella pertussis or Bordetella parapertussis.

CACMG | Comprehensive Arrhythmia and Cardiomyopathy Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of a hereditary form of either a cardiomyopathy or cardiac arrhythmia.

CAORG | Comprehensive Marfan, Loeys-Dietz, Ehlers-Danlos, and Aortopathy Gene Panel, Varies

This test is intended for establishing a diagnosis for a variety of hereditary conditions involving aortic disease or overlapping clinical presentations including Marfan syndrome, Loeys-Dietz syndrome, multiple forms of Ehlers-Danlos syndrome, heritable thoracic aortic disease/aortopathy, and others.

CARGG | Comprehensive Arrhythmia Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of a hereditary form of cardiac arrhythmia. This test is also useful for establishing a diagnosis of a hereditary form of cardiac arrhythmia.

CCMGG | Comprehensive Cardiomyopathy Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of a hereditary form of cardiomyopathy, and establishing a diagnosis of a hereditary form of cardiomyopathy.

CHDGG | Congenital Heart Disease Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history of congenital heart disease.

CMPRG | Family Member Comparator Specimen for Genome Sequencing, Varies

This test is intended for submitting a biological family member's specimen to be used as a comparator for affected patients (probands) undergoing whole genome sequencing.

CMSP | Inherited Congenital Myasthenic Syndrome Gene Panel, Varies

This test is intended primarily for establishing a molecular diagnosis for patients with congenital myasthenic syndrome.

CMVPV | Cytomegalovirus (CMV) Molecular Detection, PCR, Varies

This test is intended for rapid qualitative detection of cytomegalovirus (CMV) DNA.

CPVTG | Catecholaminergic Polymorphic Ventricular Tachycardia Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of catecholaminergic polymorphic ventricular tachycardia (CPVT).

CSPMM | Plasma Cell Myeloma Pre-Analysis Cell Sorting, Bone Marrow

This test is intended for pre-analysis cell sorting for the MayoComplete Plasma Cell Myeloma panel.

CVHBG | Comprehensive Cerebrovascular Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of a monogenic condition in which there is an increased risk for a cerebrovascular accident. This test is also useful for establishing a diagnosis of a monogenic condition in which there is an increased risk for a cerebrovascular accident.

DCLNG | Dilated Cardiomyopathy and Left Ventricular Noncompaction Cardiomyopathy Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of a hereditary form of dilated cardiomyopathy or left ventricular noncompaction as well as for establishing a diagnosis of a hereditary form dilated cardiomyopathy or left ventricular noncompaction.

DMDZ | DMD Gene, Full Gene Analysis, Varies

This test is intended for establishing a molecular diagnosis for patients with Duchenne muscular dystrophy and Becker muscular dystrophy.

DWPAN | Comprehensive Distal Weakness Gene Panel, Varies

This test is intended for establishing a molecular diagnosis for patients with distal weakness.

EBVPV | Epstein-Barr Virus (EBV), Molecular Detection, PCR, Varies

This test is intended for rapid qualitative detection of Epstein-Barr virus (EBV) DNA in specimens, and for the diagnosis of disease due to EBV.

EDMDP | Inherited Emery-Dreifuss Gene Panel, Varies

This test is intended for establishing a molecular diagnosis for patients with Emery-Dreifuss muscular dystrophy.

EDN | Eosinophil Derived Neurotoxin, Serum

This test is intended for evaluating patients suspected to have a condition associated with eosinophilia or hypereosinophilia.

EDSGG | Ehlers-Danlos Syndrome Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of Ehlers-Danlos syndrome and related conditions. This test is also intended for establishing a diagnosis for Ehlers-Danlos syndrome, X-linked occipital horn syndrome, X-linked periventricular nodular heterotopia, and brittle cornea syndrome.

EPCRB | Ehrlichia/Anaplasma, Molecular Detection, PCR, Blood

This test is intended for evaluating patients suspected of acute anaplasmosis or ehrlichiosis.

FBCQ | Benzodiazepine Confirmation, Urine

This test is only orderable as a reflex. For further information, see FSHPU/Sedative Hypnotic Panel, Urine.

FHTGF | Human Transforming Growth Factor beta 1 (TGF-b1)

HCHLG | Hypercholesterolemia Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of familial hypercholesterolemia (FH), sitosterolemia, or other monogenic forms of inherited hypercholesterolemia. This test is also useful for establishing a diagnosis of FH, sitosterolemia, or other monogenic forms of inherited hypercholesterolemia.

HCMGG | Hypertrophic Cardiomyopathy Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of a hereditary form of hypertrophic cardiomyopathy, and establishing a diagnosis of a hereditary form of hypertrophic cardiomyopathy.

HHTGG | Hereditary Hemorrhagic Telangiectasia and Vascular Malformations Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of hereditary hemorrhagic telangiectasia (HHT), cerebral cavernous malformation (CCM), capillary malformation-arteriovenous malformation syndrome (CV-AVM), or other hereditary vascular malformation syndromes of germline origin.

HIS | Histone Autoantibodies, Serum

This test is intended for evaluating patients suspected of having drug-induced lupus. This test is not useful for determining prognosis in patients with systemic lupus erythematosus or drug-induced lupus.

HSVPB | Herpes Simplex Virus (HSV), Molecular Detection, PCR, Blood

This test is intended for aiding in the rapid diagnosis of disseminated disease due to herpes simplex virus (HSV).

HSVPV | Herpes Simplex Virus (HSV), Molecular Detection, PCR, Varies

This test is intended for aiding in the rapid diagnosis of herpes simplex virus (HSV) infections, including qualitative detection of HSV DNA in nonblood clinical specimens.

HYPBG | Hypobetalipoproteinemia Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of familial hypobetalipoproteinemia.

HYPTG | Hypertriglyceridemia Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of hereditary forms of primary hypertriglyceridemia and related conditions.

IMNP | Inherited Motor Neuropathy Gene Panel, Varies

This test is intended for establishing a molecular diagnosis for patients with distal hereditary motor neuropathy (dHMN).

IMSNP | Inherited Motor and Sensory Neuropathy Gene Panel, Varies

This test is intended for establishing a molecular diagnosis for patients with hereditary motor and sensory neuropathy (HMSN) or Charcot-Marie-Tooth (CMT) disease.

ISNP | Inherited Sensory Neuropathy Gene Panel, Varies

This test is intended for establishing a molecular diagnosis for patients with hereditary sensory (HSN) and autonomic neuropathy (HSAN).

ISPP | Inherited Spastic Paraplegia Gene Panel, Varies

This test is intended for establishing a molecular diagnosis for patients with hereditary spastic paraplegia.

JCPCR | JC Virus, Molecular Detection, PCR, Spinal Fluid

This test is intended for aiding in diagnosing progressive multifocal leukoencephalopathy due to JC virus.

LGCMP | Inherited Limb-Girdle Muscular Dystrophy and Congenital Myasthenic Syndrome Gene Panel, Varies

This test is intended for establishing a molecular diagnosis for patients with limb-girdle muscular dystrophy or congenital myasthenic syndrome.

LIPOG | Lipodystrophy Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of a hereditary lipodystrophy, and for establishing a diagnosis of a hereditary lipodystrophy.

LQTSG | Long QT Syndrome Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of long QT syndrome (LQTS) as well as for establishing a diagnosis of LQTS.

LYMPV | Lyme Disease, Molecular Detection, PCR, Varies

This test is intended for supporting the diagnosis of Lyme disease in conjunction with serologic testing.

MEASR | Measles Virus, Molecular Detection, PCR, Throat

This test is intended for identifying measles virus infection using throat swab specimens.

MEASU | Measles Virus, Molecular Detection, PCR, Urine

This test is intended for identifying measles infection using random urine specimens.

MDYSP | Inherited Muscular Dystrophy Gene Panel, Varies

This test is intended for establishing a molecular diagnosis for patients with muscular dystrophy as well as identifying variants within genes known to be associated with muscular dystrophy, allowing for predictive testing of at-risk family members.

MFBNG | FBN1 Full Gene Sequencing with Deletion/Duplication, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of Marfan syndrome and other FBN1-related conditions, and for establishing a diagnosis for Marfan syndrome and other FBN1-related conditions.

MFRGG | Marfan, Loeys-Dietz, and Aortopathy Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of Marfan syndrome and related conditions. This test is also intended for establishing a diagnosis for Marfan syndrome, Loeys-Dietz syndrome, vascular Ehlers-Danlos syndrome, classic Ehlers-Danlos syndrome, and heritable thoracic aortic disease/aortopathy.

MNDP | Inherited Motor Neuron Disease Gene Panel, Varies

This test is intended for establishing a molecular diagnosis for patients with motor neuron disease, and identifying variants within genes known to be associated with motor neuron disease, allowing for predictive testing of at-risk family members.

MUMPR | Mumps Virus, Molecular Detection, PCR, Buccal

This test is intended for rapid qualitative detection of mumps virus using buccal swab specimens.

MUMPU | Mumps Virus, Molecular Detection, PCR, Urine

This test is intended for rapid qualitative detection of mumps virus using random urine specimens.

MUPAN | Comprehensive Neuromuscular Gene Panel, Varies

This test is intended for establishing a molecular diagnosis for patients with a neuromuscular disorder. This test is also used for identifying variants within genes known to be associated with neuromuscular disorders allowing for predictive testing of at-risk family members.

NGPCM | MayoComplete Plasma Cell Myeloma, Next-Generation Sequencing, Varies

This test is intended for evaluating multiple myeloma at the time of diagnosis and at disease relapse or when changing clinical management to provide prognostic information and determine potential therapeutic implications.

NSRGG | Noonan Syndrome and Related Conditions Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of Noonan syndrome, Noonan syndrome with multiple lentigines, Noonan syndrome with loose anagen hair, cardiofaciocutaneous syndrome, Costello syndrome, Baraitser-Winter syndrome, Legius syndrome, and related conditions.

OIBFG | Osteogenesis Imperfecta and Bone Fragility Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive osteogenesis imperfecta and other hereditary conditions associated with bone fragility.

PARDP | Inherited Parkinson Disease Gene Panel, Varies

This test is intended for establishing a molecular diagnosis for patients with Parkinson disease. It is also intended for identifying variants within genes known to be associated with Parkinson disease, allowing for predictive testing of at-risk family members.

PCDGG | Primary Ciliary Dyskinesia Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of primary ciliary dyskinesia, and for establishing a diagnosis of primary ciliary dyskinesia.

PEPAN | Comprehensive Peripheral Neuropathy Gene Panel, Varies

This test is intended for establishing a molecular diagnosis for patients with peripheral neuropathy.

PERAM | Perampanel, Serum

This test is intended for monitoring serum concentration of perampanel, in specific clinical conditions (ie, severe kidney impairment, mild to moderate hepatic impairment, and end-stage kidney disease).

PRKSG | PRKAR1A Full Gene Sequencing with Deletion/Duplication, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of Carney Complex (CNC) or acrodysostosis-1 with hormone resistance. This test is also useful for establishing a diagnosis of CNC or acrodysostosis-1 with hormone resistance.

RABMP | Inherited Rhabdomyolysis and Metabolic Myopathy Panel, Varies

This test is intended for establishing a molecular diagnosis for patients with rhabdomyolysis and metabolic myopathy.

REVE2 | Erythrocytosis Evaluation, Blood

This test is intended for definitive, comprehensive, and economic evaluation of an individual with JAK2-negative erythrocytosis associated with lifelong sustained increased hemoglobin or hematocrit.

SCN5A | Brugada Syndrome, SCN5A Full Gene Analysis, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of Brugada syndrome as well as establishing a diagnosis of Brugada syndrome.

SEP9Z | SEPTIN9 Gene, Full Gene Analysis, Varies

This test is intended for establishing a molecular diagnosis for patients with hereditary neuralgic amyotrophy.

SMCP | Inherited Skeletal Muscle Channelopathy Gene Panel, Varies

This test is intended for establishing a molecular diagnosis for patients with a skeletal muscle channelopathy.

SOD1Z | SOD1 Gene, Full Gene Analysis, Varies

This test is intended for identifying variants within SOD1 known to be associated with ALS, allowing for predictive testing of at-risk family members.

SSH24 | Supersaturation Profile, Self-Collect, 24 Hour, Urine

This test is intended for establishing a diagnosis and management of patients with renal lithiasis: Predicting the likely composition of the stone, in patients who have a radiopaque stone, for whom stone analysis is not available. This may help in designing a treatment program.

SUP24 | Supersaturation Profile, 24 Hour, Urine

This test is intended for predicting the likely composition of the stone, in patients who have a radiopaque stone, for whom stone analysis is not available. This may help in designing a treatment program. It is useful for aiding in identification of specific risk factors for stones using a 24-hour urine collection.

SUPRA | Supersaturation Profile, Random, Urine

This test is intended for predicting the likely composition of the stone, in patients who have a radiopaque stone, for whom stone analysis is not available. This may help in designing a treatment program.

SQTSG | Short QT Syndrome Gene Panel, Varies

This test is intended for providing a genetic evaluation for patients with a personal or family history suggestive of short QT syndrome, and for establishing a diagnosis of short QT syndrome.

TIKLB | Tick-Borne Panel, Molecular Detection, PCR, Blood

This test is intended for evaluating patients with suspected human monocytic ehrlichiosis, human granulocytic anaplasmosis, babesiosis, or Borrelia miyamotoi infection.

TTRZ | TTR Gene, Full Gene Analysis, Varies

This test is intended for establishing a molecular diagnosis for patients with amyloidosis.

VZVPV | Varicella-Zoster Virus, Molecular Detection, PCR, Varies

This test is intended for rapid (qualitative) detection of varicella-zoster virus DNA in clinical specimens for laboratory diagnosis of disease due to this virus.

WGSDX | Whole Genome Sequencing for Hereditary Disorders, Varies

This test is intended for providing a potentially cost-effective alternative to establishing a molecular diagnosis compared to performing multiple independent molecular assays.

WGSR | Whole Genome Sequencing Reanalysis, Varies

This test is intended for identifying a diagnosis or additional variants associated with the phenotype in patients who previously have had a negative or inconclusive whole genome sequencing test.